Evidence map›Paper›PMID 34344426›Full record

ArticleBreast cancer research : BCR2021

Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.

Maximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, Marie-Gabrielle Dondon, Dorothée Le Gal, Juana Beauvallet, Noura Mebirouk, Muriel Belotti, Olivier Caron, Marion Gauthier-Villars and 42 more

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Reliability and validity of adolescent idiopathic scoliosis diagnosis based on mobile phone AI scoliosis screening algorithm and infrared 3D spine assessment system.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Brca1Cancer science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

52 authors at 20 institutions in 2 countries.

Maximiliano Ribeiro GuerraINSERM, U900, Paris, France.
Juliette CoignardINSERM, U900, Paris, France.
Séverine Eon-MarchaisINSERM, U900, Paris, France.
Marie-Gabrielle DondonINSERM, U900, Paris, France.
Dorothée Le GalINSERM, U900, Paris, France.
Juana BeauvalletINSERM, U900, Paris, France.
Noura MebiroukINSERM, U900, Paris, France.
Muriel BelottiInstitut Curie, Service de Génétique, Paris, France.
Olivier CaronGustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France.
Marion Gauthier-VillarsInstitut Curie, Service de Génétique, Paris, France.
Isabelle CoupierHôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique Médicale et Oncogénétique, Montpellier, France.
Bruno BuecherInstitut Curie, Service de Génétique, Paris, France.
Alain LortholaryCentre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France.
Jean-Pierre FrickerCentre Paul Strauss, Unité d'Oncologie, Strasbourg, France.
Paul GestaCH Georges Renon, Service d'Oncogénétique Régional Poitou-Charentes, Niort, France.
Catherine NoguèsDépartement d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli Calmettes, Marseille, France.
Laurence FaivreInstitut GIMI, CHU de Dijon, Hôpital d'Enfants, Dijon, France.
Pascaline BerthetCentre François Baclesse, Unité de pathologie gynécologique, Caen, France.
Elisabeth LuporsiService de Génétique UF4128 CHR Metz-Thionville, Hôpital de Mercy, Metz, France.
Capucine DelnatteCentre René Gauducheau, Unité d'Oncogénétique, Nantes, Saint Herblain, France.
Valérie BonadonaUniversité Claude Bernard Lyon 1, Villeurbanne, France.
Christine M MaugardGénétique Oncologique moléculaire, UF1422, Département d'Oncobiologie, LBBM, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Pascal PujolHôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique Médicale et Oncogénétique, Montpellier, France.
Christine LassetUniversité Claude Bernard Lyon 1, Villeurbanne, France.
Michel LongyInstitut Bergonié, Bordeaux, France.
Yves-Jean BignonDépartement d'oncogénétique, Centre Jean Perrin, Université Clermont Auvergne, UMR INSERM 1240, Clermont Ferrand, France.
Claude Adenis-LavignassePolyclinique de la Louvière (groupe Ramsay), Lille, France.
Laurence Venat-BouvetService d'Oncologie Médicale, Hôpital Universitaire Dupuytren, Limoges, France.
Hélène DreyfusClinique Sainte Catherine, Avignon, France.
Laurence GladieffInstitut Claudius Regaud - IUCT-Oncopole, Service d'Oncologie Médicale, Toulouse, France.
Isabelle MortemousqueService de Génétique, Hôpital Bretonneau, Tours, France.
Séverine Audebert-BellangerDépartement de Génétique Médicale et Biologie de la Reproduction, Hôpital Morvan, CHU Brest, Brest, France.
Florent SoubrierHôpital Tenon, Paris, France.
Sophie GiraudHospices Civils de Lyon, Service de Génétique, Groupement Hospitalier EST, Bron, France.
Sophie Lejeune-DumoulinClinique de Génétique Médicale Guy Fontaine, CHU Lille, Lille, France.
Jean-Marc LimacherService d'Onco-hématologie, Hôpital Pasteur, Colmar, France.
Jean ChiesaService d'Oncologie Médicale, CHRU Hôpital Caremeau, Nîmes, France.
Anne FajacService d'Oncogénétique, Hôpital Tenon, Paris, France.
Anne FloquetInstitut Bergonié, Bordeaux, France.
François EisingerDépartement d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli Calmettes, Marseille, France.
Julie TinatGroupe Hospitalier Pellegrin, Service de génétique médicale, CHU De Bordeaux, Bordeaux, France.
Sandra Fert-FerrerCentre Hospitalier Métropole Savoie, Chambéry, France.
Chrystelle ColasInstitut Curie, Service de Génétique, Paris, France.
Thierry FrebourgDépartement de Génétique, Hopital Universitaire de Rouen, Rouen, France.
Francesca DamiolaDepartment of Biopathology, Pathology Research platform, Centre Léon Bérard, Lyon, France.
Laure BarjhouxGCS AURAGEN, Plateforme de Génétique, Hôpital Edouart Herriot, Lyon, France.
Eve CavaciutiINSERM, U900, Paris, France.
Sylvie MazoyerCentre de Recherche en Neurosciences de Lyon, INSERM U1028, CNRS UMR5292, Université Lyon 1, Université Saint Etienne, Lyon, France.
Anne TardivonService de Radiologie, Institut Curie, Paris, France.
Fabienne LesueurINSERM, U900, Paris, France.
Dominique Stoppa-LyonnetInstitut Curie, Service de Génétique, Paris, France.
Nadine AndrieuINSERM, U900, Paris, France. nadine.andrieu@curie.fr.ORCID 0000-0001-8820-5550
Inserm · FRInstitut Curie · FRUniversité Claude Bernard Lyon 1 · FRHospices Civils de Lyon · FRInstitut Bergonié · FRSorbonne Université · FRCentre François Baclesse · FRCentre Georges François Leclerc · FRCentre Hospitalier de Niort · FRCentre Hospitalier Métropole Savoie · FRCentre Hospitalier Régional Universitaire de Brest · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Lille · FRCentre Hospitalier Universitaire de Nîmes · FRCentre Hospitalier Universitaire de Rouen · FRCentre Hospitalier Universitaire de Tours · FRCentre Léon Bérard · FRDélégation Paris 5 · FRHôpital Femme Mère Enfant · FR

Funding

Brazilian National Council for the Improvement of Higher Education - CAPES BEX 5852/15-3Institut National Du Cancer b2008-029/LL-LCLigue Contre le Cancer PRE05/DSLLigue Contre le Cancer PRE07/DSLLigue Contre le Cancer PRE11/NAthe comprehensive cancer center SiRIC INCa-DGOS-4654
6 · The paper itself

Abstract

backgroundDiagnostic ionizing radiation is a risk factor for breast cancer (BC). BC risk increases with increased dose to the chest and decreases with increased age at exposure, with possible effect modification related to familial or genetic predisposition. While chest X-rays increase the BC risk of BRCA1/2 mutation carriers compared to non-carriers, little is known for women with a hereditary predisposition to BC but who tested negative for a BRCA1 or BRCA2 (BRCA1/2) mutation.

methodsWe evaluated the effect of chest X-rays from diagnostic medical procedures in a dataset composed of 1552 BC cases identified through French family cancer clinics and 1363 unrelated controls. Participants reported their history of X-ray exposures in a detailed questionnaire and were tested for 113 DNA repair genes. Logistic regression and multinomial logistic regression models were used to assess the association with BC.

resultsChest X-ray exposure doubled BC risk. A 3% increased BC risk per additional exposure was observed. Being 20 years old or younger at first exposure or being exposed before first full-term pregnancy did not seem to modify this risk. Birth after 1960 or carrying a rare likely deleterious coding variant in a DNA repair gene other than BRCA1/2 modified the effect of chest X-ray exposure.

conclusionEver/never chest X-ray exposure increases BC risk 2-fold regardless of age at first exposure and, by up to 5-fold when carrying 3 or more rare variants in a DNA repair gene. Further studies are needed to evaluate other DNA repair genes or variants to identify those which could modify radiation sensitivity. Identification of subpopulations that are more or less susceptible to ionizing radiation is important and potentially clinically relevant.

Indexed as

AdultBreast NeoplasmsDNA RepairFemaleGenes, BRCA1Genes, BRCA2Genetic Predisposition to DiseaseHumansMiddle AgedMutationRadiographyRiskRisk FactorsYoung AdultBreast cancerDNA repair genesHigh-risk populationLow doseX-ray exposure

Identifiers

PMID34344426
PMCPMC8336294
OpenAlexW3187781948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.